Most Relevant Terms per Topic

Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 24

Topic 1 Topic 2 Topic 3 Topic 4 Topic 5 Topic 6 Topic 7 Topic 8 Topic 9 Topic 10 Topic 11 Topic 12 Topic 13 Topic 14 Topic 15
1 % influenza care COVID-19 factors 95 critically ECMO ARDS group treatment children SARS MERS SARI
2 patients ICU management wuhan risk CI critically ill oxygenation sepsis VAP antiviral CAP acute respiratory syndrome mers-cov scores
3 hospital virus disease 2019 AKI in-hospital mortality ill extracorporeal shock bronchiolitis dose PICU workers ED recovery
4 days respiratory intensive sars-cov-2 risk factors in-hospital NIV membrane septic groups clearance RSV kong middle tpa
5 years viral specific coronavirus kidney interval invasive prone septic shock ventilator-associated ribavirin pneumonia hong east TACS
6 clinical H1N1 improve 2020 regression confidence interval ventilation extracorporeal membrane oxygenation distress infants therapy pneumoniae acute saudi MATERIAL
7 median 2009 supportive disease serum confidence intubation mmhg dysfunction rate treated community-acquired pneumonia 2003 middle east respiratory syndrome material
8 age patients include cardiac independent % HFNC rescue AGI mechanically respiratory failure pathogens acute renal impairment arabia curve
9 1 intensive chronic obstructive pulmonary disease china analysis = failure pao(2)/fio(2 lung ventilated RNA readmission hong kong saudi arabia supplementary
10 - co-infection studies coronavirus disease 2019 multivariate odds noninvasive positioning pulmonary events cidofovir identification health-care mers-cov infection SUPPLEMENTARY
11 data bacterial early severe levels odds ratio non-invasive tidal perfusion MDR cultures admissions health care workers hcws specificity
12 results viruses remains patients increase ratio acute respiratory failure rescue therapy fluid ventilator-associated pneumonia delayed community-acquired health 2015 score
13 died intensive care unit patients hypertension 95%CI MV invasive ventilation ± inflammation IABP isolation hospitalisation NIPPV middle east respiratory syndrome coronavirus H7N9
14 outcomes admitted obstructive cardiac injury CRP adjusted noninvasive ventilation prone positioning acute respiratory distress syndrome mechanically ventilated oseltamivir aureus health-care workers outbreak online
15 included pneumonia measures death age arrest IMV transport systemic recorded treated with ventilator‐associated syndrome statistically version
16 5 infections high 2019-ncov logistic < nasal position edema ventilator-associated events combination congenital NPPV revisits recovery delay
17 range unit morbidity covid-19 pneumonia progression ffas high-flow hypoxemia biomarkers ALA patient SCAP non-invasive ventilation HH authorized
18 onset infection review CML c-reactive aor oxygen support vascular control group viral rna APMV non‐pregnant expired tdl-vent
19 admitted admission quality cough CRRT mortality IPA volume oxygenated relocation methylprednisolone streptococcus world A(H7N9 SVS
20 total respiratory viruses research comorbidities count NVHAP cannula pertussis response FOB empiric neurologic disorders impairment 72-hour calculated
21 confirmed care potential jan cox length of stay respiratory HFOV hg preterm vitamin streptococcus pneumoniae P= emergency department delay
22 14 severe respiratory feb LDH 0.001 CS refractory injury length intravenous LOS airborne 0.05 ELECTRONIC
23 10 chain interventions older associated with cardiopulmonary ventilatory ventilator damage CXR administration NP contact visit dataset
24 study reaction diagnosis cardiovascular disease prognostic spo2 respiratory support safe blood placebo recipients underlying ARF corona mers‐cov
25 cases icu admission infectious fever higher RSI high-flow nasal cannula vs. host desaturation anti-pcp microbial pneumothorax corona virus PTSD
26 15 pandemic staff cases mortality hazard support gas coagulation snps transplant non-neurologic renal 138 LT
27 illness detection cancer type development hospitals success lung PARDS breastfeeding vitamin c viral identification regional king validation
28 25 similar COPD cardiovascular c-reactive protein associated with strict successfully diffuse IFV remdesivir ACT I/D department CT
29 characteristics viral pneumonia treatment pneumonia predicted versus mask tidal volume saline control antiviral therapy aeruginosa susceptibility adult discharge
30 outcome APACHE systems injury prognostic factors baseline controversial DU pancreatitis 60-day failure prospective study ACE statistically significant users
31 methods pregnant literature male study independently avoid pressure h1n1 influenza mechanical ventilation time persons barotrauma visits TDL
32 period icus including interpretation protein corticosteroids pulmonary conventional zheng differ antibiotics resistant world health organization renal psychological
33 occurred 2016 unit electronic medical records acute kidney injury cardiopulmonary arrest components ARDS viral load group i TB staphylococcus 0.006 korea TRPV1
34 20 adult acute non-survivors albumin LRI treatment failure ecmonet animals VAE presented anaerobic polymorphism demographic information AUC
35 describe requiring requires methods dehydrogenase hazard ratio attempt km malaria group ii pulsed antibiotic intubation riyadh algorithm
36 discharged HAP acute exacerbations coronavirus disease early macrolide therapy (h1n1)v activity syndrome assigned adv suspected respiratory ORA 77
37 18 polymerase chapter antibody patients COVID−19 piperacillin minutes arterial HMPV high dose disorders non-invasive CFR 0
38 = measles infection igg clinicians stratification piperacillin-tazobactam ratios multiple intermittent kidney transplant conditions march mers-cov. 24
39 IQR tested past AMI lymphocyte .01 oedema PP acute difference PCP neurologic airflow P=0.001 VZV-CAP
40 31 mechanical understanding non-severe hospitalized abstracted ETI ventilation yang-xu significantly broad-spectrum antibiotics seng abdulaziz stationary
41 11 mechanical ventilation increasingly nt-probnp univariate CA-RVI SOFA pump horses stay hadv-55 prematurity tock insurance ROC
42 21 mortality intensive care unit sars-cov-2 pneumonia level cardiac arrest patients end-expiratory fulminant cuff RP MPP tan interferon rrt‐pcr
43 17 a(h1n1)pdm09 associated with characteristics severity por extremely cmh(2)o glutathione ADE resolution S. plasma creatinine largest HRQL
44 rate A(H1N1 pulmonary common aminotransferase university-affiliated tazobactam prone position overload suction hemodialysis 310 sars-coronavirus emergency assessment
45 high respiratory virus patient diseases platelet mmol/l first-line therapy 200 fluid therapy hmpv-associated viral asp tan tock seng hospital pediatric transition
46 admission RVP scoring conclusions proportional non-transplant guangdong province interstitial axis pilot supportive treatment aged 401 king abdulaziz medical city PAMV
47 27 pregnant women recommended computed aspartate ca-rvs h1n1 virus infection severe acute pancreatitis usefulness IFN pathogen contracting health insurance coverage PRESERVE
48 22 immunocompetent crucial lymphocytes death IHCA bronchoscopy paco(2 organ mechanical hadv type allele practices characteristic
49 retrospectively acute lack lymphocytopenia serum creatinine feeding 2nd training pediatric = hiv-negative incidence sars-coronavirus infection mers-designated survival group
50 29 coinfection procedures clinical proteinuria G2 PIC paralysis activation ventilation benefits picus aerosol-generating procedures rate doi:10.1007/s00134